Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide
Authors:
- 1 August 2014
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 73, 291-298
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repairBritish Journal of Cancer, 2013
- Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinomaRadiation Oncology, 2012
- Targeted Cancer Therapy: Giving Histone Deacetylase Inhibitors All They Need To SucceedFuture Medicinal Chemistry, 2012
- HDAC Inhibitor, Valproic Acid, Induces p53-Dependent Radiosensitization of Colon Cancer CellsCancer Biotherapy and Radiopharmaceuticals, 2009
- The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidationFree Radical Biology and Medicine, 2009
- Vorinostat in solid and hematologic malignanciesJournal of Hematology & Oncology, 2009
- The emergence of nitroxyl (HNO) as a pharmacological agentBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancerInvestigational New Drugs, 2008
- Radiosensitization by Nitric Oxide at Low Radiation DosesRadiation Research, 2007
- Antioxidant actions of nitroxyl (HNO)Free Radical Biology and Medicine, 2007